{
  "data": {
    "id": "org_us-food-and-drug-administration",
    "slug": "us-food-and-drug-administration",
    "name": "U.S. Food and Drug Administration",
    "short_name": "FDA",
    "type": "government",
    "tier": 1,
    "homepage": "https://www.fda.gov",
    "country_code": "US",
    "reliability_note": null,
    "url": "https://statorigin.org/sources/us-food-and-drug-administration",
    "documents": [
      {
        "title": "FDA Seeks Public Input to Advance Development of Botanical Drug Products",
        "url": "https://www.fda.gov/news-events/press-announcements/fda-seeks-public-input-advance-development-botanical-drug-products",
        "doc_type": "press_release",
        "published_date": null,
        "accessed_at": "2026-09-17",
        "license": "see-source",
        "url_status": "ok",
        "statistic_count": 1
      },
      {
        "title": "Novel Drug Approvals for 2024",
        "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2024",
        "doc_type": "press_release",
        "published_date": null,
        "accessed_at": "2026-09-17",
        "license": "see-source",
        "url_status": "ok",
        "statistic_count": 1
      },
      {
        "title": "Novel Drug Approvals for 2025",
        "url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2025",
        "doc_type": "press_release",
        "published_date": null,
        "accessed_at": "2026-09-17",
        "license": "see-source",
        "url_status": "ok",
        "statistic_count": 1
      },
      {
        "title": "CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024",
        "url": "https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024",
        "doc_type": "press_release",
        "published_date": null,
        "accessed_at": "2026-09-17",
        "license": "see-source",
        "url_status": "ok",
        "statistic_count": 15
      }
    ],
    "statistics": [
      {
        "id": "stat_GJ0HSPRESAY30Y07N4XMBZF857",
        "url": "https://statorigin.org/stat/stat_GJ0HSPRESAY30Y07N4XMBZF857",
        "indicator": {
          "slug": "biosimilar-biological-product-approvals",
          "name": "Biosimilar biological product approvals",
          "definition": "Number of biosimilar biological products approved during the period."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "US",
          "name": "United States",
          "type": "country"
        },
        "period": {
          "start": "2024-01-01",
          "end": "2024-12-31",
          "type": "year"
        },
        "value": 18,
        "value_text": "18",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "U.S. Food and Drug Administration",
          "org_short_name": "FDA",
          "org_url": "https://www.fda.gov",
          "org_tier": 1,
          "document_title": "CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024",
          "document_url": "https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024",
          "document_type": "press_release",
          "locator": "A Record Year for Biosimilar Approvals",
          "quote": "This milestone is due to CDER approving in 2024 a record total of 18 biosimilars for 8 reference products, more than any previous year.",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "U.S. Food and Drug Administration. (2024). CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024. Retrieved September 17, 2026, from https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Via StatOrigin, https://statorigin.org/stat/stat_GJ0HSPRESAY30Y07N4XMBZF857",
          "bibtex": "@misc{fda2024biosimilarbzf857,\n  author       = {{U.S. Food and Drug Administration}},\n  title        = {CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024},\n  year         = {2024},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_GJ0HSPRESAY30Y07N4XMBZF857},\n  note         = {Original source: https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_NRSYQY2AXZDY94AMEFRD5DCGKY",
        "url": "https://statorigin.org/stat/stat_NRSYQY2AXZDY94AMEFRD5DCGKY",
        "indicator": {
          "slug": "botanical-drug-products-approved-as-prescription-drugs",
          "name": "Botanical drug products approved as prescription drugs",
          "definition": "Cumulative number of botanical drug products approved for marketing as prescription drugs through new drug applications."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "US",
          "name": "United States",
          "type": "country"
        },
        "period": {
          "start": "2026-09-03",
          "end": "2026-09-03",
          "type": "point"
        },
        "value": 4,
        "value_text": "four",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "U.S. Food and Drug Administration",
          "org_short_name": "FDA",
          "org_url": "https://www.fda.gov",
          "org_tier": 1,
          "document_title": "FDA Seeks Public Input to Advance Development of Botanical Drug Products",
          "document_url": "https://www.fda.gov/news-events/press-announcements/fda-seeks-public-input-advance-development-botanical-drug-products",
          "document_type": "press_release",
          "locator": "FDA Seeks Public Input to Advance Development of Botanical Drug Products",
          "quote": "To date, four botanical products have been approved for marketing as prescription drugs through the FDA’s new drug application and biologics license application pathways.",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "U.S. Food and Drug Administration. (2026). FDA Seeks Public Input to Advance Development of Botanical Drug Products. Retrieved September 17, 2026, from https://www.fda.gov/news-events/press-announcements/fda-seeks-public-input-advance-development-botanical-drug-products. Via StatOrigin, https://statorigin.org/stat/stat_NRSYQY2AXZDY94AMEFRD5DCGKY",
          "bibtex": "@misc{fda2026botanical5dcgky,\n  author       = {{U.S. Food and Drug Administration}},\n  title        = {FDA Seeks Public Input to Advance Development of Botanical Drug Products},\n  year         = {2026},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_NRSYQY2AXZDY94AMEFRD5DCGKY},\n  note         = {Original source: https://www.fda.gov/news-events/press-announcements/fda-seeks-public-input-advance-development-botanical-drug-products. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_92Y7GY7XN338491G60KZNPBNHR",
        "url": "https://statorigin.org/stat/stat_92Y7GY7XN338491G60KZNPBNHR",
        "indicator": {
          "slug": "cumulative-biosimilar-approvals",
          "name": "Cumulative biosimilar approvals",
          "definition": "Cumulative total number of biosimilar biological products approved since inception."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "US",
          "name": "United States",
          "type": "country"
        },
        "period": {
          "start": "2015-01-01",
          "end": "2024-12-31",
          "type": "year"
        },
        "value": 60,
        "value_text": "60th",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "U.S. Food and Drug Administration",
          "org_short_name": "FDA",
          "org_url": "https://www.fda.gov",
          "org_tier": 1,
          "document_title": "CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024",
          "document_url": "https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024",
          "document_type": "press_release",
          "locator": "A Record Year for Biosimilar Approvals",
          "quote": "CDER surpassed a major approval milestone for biosimilar biological products (biosimilars) in 2024 when it approved the 60th biosimilar since the first biosimilar approval in 2015.",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "U.S. Food and Drug Administration. (2024). CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024. Retrieved September 17, 2026, from https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Via StatOrigin, https://statorigin.org/stat/stat_92Y7GY7XN338491G60KZNPBNHR",
          "bibtex": "@misc{fda2024cumulativenpbnhr,\n  author       = {{U.S. Food and Drug Administration}},\n  title        = {CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024},\n  year         = {2024},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_92Y7GY7XN338491G60KZNPBNHR},\n  note         = {Original source: https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_7HV4S9S7GYPN08FQAGH9VPCWB5",
        "url": "https://statorigin.org/stat/stat_7HV4S9S7GYPN08FQAGH9VPCWB5",
        "indicator": {
          "slug": "first-cycle-novel-drug-approvals",
          "name": "First-cycle novel drug approvals",
          "definition": "Number of novel drugs approved on the first regulatory review cycle."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "US",
          "name": "United States",
          "type": "country"
        },
        "period": {
          "start": "2024-01-01",
          "end": "2024-12-31",
          "type": "year"
        },
        "value": 37,
        "value_text": "37",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "U.S. Food and Drug Administration",
          "org_short_name": "FDA",
          "org_url": "https://www.fda.gov",
          "org_tier": 1,
          "document_title": "CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024",
          "document_url": "https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024",
          "document_type": "press_release",
          "locator": "CDER’s Effectiveness Bringing New Therapies to Market",
          "quote": "First Cycle Approvals: 37 of the 50 novel drugs approved in 2024 (74%) were approved on the “first cycle” of review.",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "U.S. Food and Drug Administration. (2024). CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024. Retrieved September 17, 2026, from https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Via StatOrigin, https://statorigin.org/stat/stat_7HV4S9S7GYPN08FQAGH9VPCWB5",
          "bibtex": "@misc{fda2024firstvpcwb5,\n  author       = {{U.S. Food and Drug Administration}},\n  title        = {CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024},\n  year         = {2024},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_7HV4S9S7GYPN08FQAGH9VPCWB5},\n  note         = {Original source: https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_FGN4ATG2813DKK24SP6N6W5BDM",
        "url": "https://statorigin.org/stat/stat_FGN4ATG2813DKK24SP6N6W5BDM",
        "indicator": {
          "slug": "interchangeable-biosimilar-approvals",
          "name": "Interchangeable biosimilar approvals",
          "definition": "Number of interchangeable biosimilar biological products approved during the period."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "US",
          "name": "United States",
          "type": "country"
        },
        "period": {
          "start": "2024-01-01",
          "end": "2024-12-31",
          "type": "year"
        },
        "value": 9,
        "value_text": "9",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "U.S. Food and Drug Administration",
          "org_short_name": "FDA",
          "org_url": "https://www.fda.gov",
          "org_tier": 1,
          "document_title": "CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024",
          "document_url": "https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024",
          "document_type": "press_release",
          "locator": "A Record Year for Biosimilar Approvals",
          "quote": "Also in 2024, CDER approved 9 interchangeable biosimilars (for new and previously approved biosimilars).",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "U.S. Food and Drug Administration. (2024). CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024. Retrieved September 17, 2026, from https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Via StatOrigin, https://statorigin.org/stat/stat_FGN4ATG2813DKK24SP6N6W5BDM",
          "bibtex": "@misc{fda2024interchangeable6w5bdm,\n  author       = {{U.S. Food and Drug Administration}},\n  title        = {CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024},\n  year         = {2024},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_FGN4ATG2813DKK24SP6N6W5BDM},\n  note         = {Original source: https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_DTVZ86ZKKFMY4BRZGE6MNCJGKA",
        "url": "https://statorigin.org/stat/stat_DTVZ86ZKKFMY4BRZGE6MNCJGKA",
        "indicator": {
          "slug": "novel-antibiotic-approvals",
          "name": "Novel antibiotic approvals",
          "definition": "Number of new antibiotic therapies approved by regulatory authorities during the period."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "US",
          "name": "United States",
          "type": "country"
        },
        "period": {
          "start": "2024-01-01",
          "end": "2024-12-31",
          "type": "year"
        },
        "value": 3,
        "value_text": "three",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "U.S. Food and Drug Administration",
          "org_short_name": "FDA",
          "org_url": "https://www.fda.gov",
          "org_tier": 1,
          "document_title": "CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024",
          "document_url": "https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024",
          "document_type": "press_release",
          "locator": "Creating a Yearly Snapshot for Approvals",
          "quote": "The 2024 report includes approvals for therapies that collectively treat a wide range of conditions, including a first-in-class drug for schizophrenia, three novel antibiotics and new drugs for many types of cancer.",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "U.S. Food and Drug Administration. (2024). CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024. Retrieved September 17, 2026, from https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Via StatOrigin, https://statorigin.org/stat/stat_DTVZ86ZKKFMY4BRZGE6MNCJGKA",
          "bibtex": "@misc{fda2024novelncjgka,\n  author       = {{U.S. Food and Drug Administration}},\n  title        = {CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024},\n  year         = {2024},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_DTVZ86ZKKFMY4BRZGE6MNCJGKA},\n  note         = {Original source: https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_YPEXVA6CNFQ4Q0A2YJX9PFV0GE",
        "url": "https://statorigin.org/stat/stat_YPEXVA6CNFQ4Q0A2YJX9PFV0GE",
        "indicator": {
          "slug": "novel-drug-approvals",
          "name": "Novel drug approvals",
          "definition": "Total number of novel drugs approved for the first time by a regulatory authority within a calendar year."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "US",
          "name": "United States",
          "type": "country"
        },
        "period": {
          "start": "2024-01-01",
          "end": "2024-12-31",
          "type": "year"
        },
        "value": 50,
        "value_text": "50",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "U.S. Food and Drug Administration",
          "org_short_name": "FDA",
          "org_url": "https://www.fda.gov",
          "org_tier": 1,
          "document_title": "Novel Drug Approvals for 2024",
          "document_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2024",
          "document_type": "press_release",
          "locator": "FDA Novel Drug Therapy Approvals for 2024",
          "quote": "In 2024, CDER approved 50 new drugs never before approved or marketed in the U.S., known as “novel” drugs.",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "U.S. Food and Drug Administration. (2024). Novel Drug Approvals for 2024. Retrieved September 17, 2026, from https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2024. Via StatOrigin, https://statorigin.org/stat/stat_YPEXVA6CNFQ4Q0A2YJX9PFV0GE",
          "bibtex": "@misc{fda2024novelpfv0ge,\n  author       = {{U.S. Food and Drug Administration}},\n  title        = {Novel Drug Approvals for 2024},\n  year         = {2024},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_YPEXVA6CNFQ4Q0A2YJX9PFV0GE},\n  note         = {Original source: https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2024. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_FYPH5BNZDF28G5Z8B3HWEGC64Z",
        "url": "https://statorigin.org/stat/stat_FYPH5BNZDF28G5Z8B3HWEGC64Z",
        "indicator": {
          "slug": "novel-drug-approvals",
          "name": "Novel drug approvals",
          "definition": "Total number of novel drugs approved for the first time by a regulatory authority within a calendar year."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "US",
          "name": "United States",
          "type": "country"
        },
        "period": {
          "start": "2025-01-01",
          "end": "2025-12-31",
          "type": "year"
        },
        "value": 46,
        "value_text": "46",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "U.S. Food and Drug Administration",
          "org_short_name": "FDA",
          "org_url": "https://www.fda.gov",
          "org_tier": 1,
          "document_title": "Novel Drug Approvals for 2025",
          "document_url": "https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2025",
          "document_type": "press_release",
          "locator": "FDA Novel Drug Therapy Approvals for 2025",
          "quote": "In 2025, CDER approved 46 new drugs never before approved or marketed in the U.S., known as “novel” drugs.",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "U.S. Food and Drug Administration. (2025). Novel Drug Approvals for 2025. Retrieved September 17, 2026, from https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2025. Via StatOrigin, https://statorigin.org/stat/stat_FYPH5BNZDF28G5Z8B3HWEGC64Z",
          "bibtex": "@misc{fda2025novelegc64z,\n  author       = {{U.S. Food and Drug Administration}},\n  title        = {Novel Drug Approvals for 2025},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_FYPH5BNZDF28G5Z8B3HWEGC64Z},\n  note         = {Original source: https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2025. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_490P1RBES11QSCWQYHPQ8YMMZH",
        "url": "https://statorigin.org/stat/stat_490P1RBES11QSCWQYHPQ8YMMZH",
        "indicator": {
          "slug": "novel-drug-approvals",
          "name": "Novel drug approvals",
          "definition": "Total number of novel drugs approved for the first time by a regulatory authority within a calendar year."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "US",
          "name": "United States",
          "type": "country"
        },
        "period": {
          "start": "2024-01-01",
          "end": "2024-12-31",
          "type": "year"
        },
        "value": 50,
        "value_text": "50",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "U.S. Food and Drug Administration",
          "org_short_name": "FDA",
          "org_url": "https://www.fda.gov",
          "org_tier": 1,
          "document_title": "CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024",
          "document_url": "https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024",
          "document_type": "press_release",
          "locator": "New Rare Disease Therapies in 2024",
          "quote": "In 2024, CDER approved 50 new drugs that had active ingredients not previously approved by the FDA.",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "U.S. Food and Drug Administration. (2024). CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024. Retrieved September 17, 2026, from https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Via StatOrigin, https://statorigin.org/stat/stat_490P1RBES11QSCWQYHPQ8YMMZH",
          "bibtex": "@misc{fda2024novel8ymmzh,\n  author       = {{U.S. Food and Drug Administration}},\n  title        = {CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024},\n  year         = {2024},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_490P1RBES11QSCWQYHPQ8YMMZH},\n  note         = {Original source: https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_JNK8ARWY2PGWWRZKZ7HYNGAPKT",
        "url": "https://statorigin.org/stat/stat_JNK8ARWY2PGWWRZKZ7HYNGAPKT",
        "indicator": {
          "slug": "novel-drug-approvals-meeting-user-fee-goal-dates",
          "name": "Novel drug approvals meeting user fee goal dates",
          "definition": "Number of novel drug approvals concluded within standard statutory or user fee review timelines."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "US",
          "name": "United States",
          "type": "country"
        },
        "period": {
          "start": "2024-01-01",
          "end": "2024-12-31",
          "type": "year"
        },
        "value": 47,
        "value_text": "47",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "U.S. Food and Drug Administration",
          "org_short_name": "FDA",
          "org_url": "https://www.fda.gov",
          "org_tier": 1,
          "document_title": "CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024",
          "document_url": "https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024",
          "document_type": "press_release",
          "locator": "CDER’s Effectiveness Bringing New Therapies to Market",
          "quote": "User Fee Goal Performance: In 2024, CDER met or exceeded its Prescription Drug User Fee Act goal date for 47 of the 50 novel drug approvals (94%).",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "U.S. Food and Drug Administration. (2024). CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024. Retrieved September 17, 2026, from https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Via StatOrigin, https://statorigin.org/stat/stat_JNK8ARWY2PGWWRZKZ7HYNGAPKT",
          "bibtex": "@misc{fda2024novelngapkt,\n  author       = {{U.S. Food and Drug Administration}},\n  title        = {CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024},\n  year         = {2024},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_JNK8ARWY2PGWWRZKZ7HYNGAPKT},\n  note         = {Original source: https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_E42Q7GDFNTTE16PB42TN238EC2",
        "url": "https://statorigin.org/stat/stat_E42Q7GDFNTTE16PB42TN238EC2",
        "indicator": {
          "slug": "novel-drug-approvals-using-expedited-programs",
          "name": "Novel drug approvals using expedited programs",
          "definition": "Number of novel therapies approved through one or more expedited regulatory review pathways."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "US",
          "name": "United States",
          "type": "country"
        },
        "period": {
          "start": "2024-01-01",
          "end": "2024-12-31",
          "type": "year"
        },
        "value": 33,
        "value_text": "33",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "U.S. Food and Drug Administration",
          "org_short_name": "FDA",
          "org_url": "https://www.fda.gov",
          "org_tier": 1,
          "document_title": "CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024",
          "document_url": "https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024",
          "document_type": "press_release",
          "locator": "CDER’s Effectiveness Bringing New Therapies to Market",
          "quote": "Expedited Programs: In 2024, CDER approved 33 of the 50 new therapies (66%) using one or more expedited approval programs: fast track designation, breakthrough therapy designation, priority review designation, and Accelerated Approval.",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "U.S. Food and Drug Administration. (2024). CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024. Retrieved September 17, 2026, from https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Via StatOrigin, https://statorigin.org/stat/stat_E42Q7GDFNTTE16PB42TN238EC2",
          "bibtex": "@misc{fda2024novel238ec2,\n  author       = {{U.S. Food and Drug Administration}},\n  title        = {CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024},\n  year         = {2024},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_E42Q7GDFNTTE16PB42TN238EC2},\n  note         = {Original source: https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_QTAGJ6V8283NFRV6FMA50ER0VJ",
        "url": "https://statorigin.org/stat/stat_QTAGJ6V8283NFRV6FMA50ER0VJ",
        "indicator": {
          "slug": "novel-drugs-approved-first-in-domestic-market",
          "name": "Novel drugs approved first in domestic market",
          "definition": "Number of novel drugs approved in the reporting jurisdiction prior to receiving approval in other jurisdictions."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "US",
          "name": "United States",
          "type": "country"
        },
        "period": {
          "start": "2024-01-01",
          "end": "2024-12-31",
          "type": "year"
        },
        "value": 34,
        "value_text": "34",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "U.S. Food and Drug Administration",
          "org_short_name": "FDA",
          "org_url": "https://www.fda.gov",
          "org_tier": 1,
          "document_title": "CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024",
          "document_url": "https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024",
          "document_type": "press_release",
          "locator": "CDER’s Effectiveness Bringing New Therapies to Market",
          "quote": "Approval in the U.S. Before Other Countries: In 2024, 34 of the 50 novel drugs approved by CDER (68%) were approved in the U.S. before being approved in other countries.",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "U.S. Food and Drug Administration. (2024). CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024. Retrieved September 17, 2026, from https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Via StatOrigin, https://statorigin.org/stat/stat_QTAGJ6V8283NFRV6FMA50ER0VJ",
          "bibtex": "@misc{fda2024novel0er0vj,\n  author       = {{U.S. Food and Drug Administration}},\n  title        = {CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024},\n  year         = {2024},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_QTAGJ6V8283NFRV6FMA50ER0VJ},\n  note         = {Original source: https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_PZ8Y4T826CBFBEP23NPCHYCTMV",
        "url": "https://statorigin.org/stat/stat_PZ8Y4T826CBFBEP23NPCHYCTMV",
        "indicator": {
          "slug": "orphan-drug-approvals",
          "name": "Orphan drug approvals",
          "definition": "Number of therapies targeting rare diseases approved after receiving an orphan drug designation."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "US",
          "name": "United States",
          "type": "country"
        },
        "period": {
          "start": "2024-01-01",
          "end": "2024-12-31",
          "type": "year"
        },
        "value": 26,
        "value_text": "26",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "U.S. Food and Drug Administration",
          "org_short_name": "FDA",
          "org_url": "https://www.fda.gov",
          "org_tier": 1,
          "document_title": "CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024",
          "document_url": "https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024",
          "document_type": "press_release",
          "locator": "New Rare Disease Therapies in 2024",
          "quote": "These approvals included 26 new therapies that had previously received an orphan drug designation to prevent, diagnose or treat a rare disease or condition.",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "U.S. Food and Drug Administration. (2024). CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024. Retrieved September 17, 2026, from https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Via StatOrigin, https://statorigin.org/stat/stat_PZ8Y4T826CBFBEP23NPCHYCTMV",
          "bibtex": "@misc{fda2024orphanhyctmv,\n  author       = {{U.S. Food and Drug Administration}},\n  title        = {CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024},\n  year         = {2024},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_PZ8Y4T826CBFBEP23NPCHYCTMV},\n  note         = {Original source: https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_60N9V7K4M162PZDBQ1S0114PD7",
        "url": "https://statorigin.org/stat/stat_60N9V7K4M162PZDBQ1S0114PD7",
        "indicator": {
          "slug": "reference-products-with-biosimilar-approvals",
          "name": "Reference products with biosimilar approvals",
          "definition": "Number of originator biological reference products for which biosimilar therapies have been approved."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "US",
          "name": "United States",
          "type": "country"
        },
        "period": {
          "start": "2024-01-01",
          "end": "2024-12-31",
          "type": "year"
        },
        "value": 8,
        "value_text": "8",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "U.S. Food and Drug Administration",
          "org_short_name": "FDA",
          "org_url": "https://www.fda.gov",
          "org_tier": 1,
          "document_title": "CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024",
          "document_url": "https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024",
          "document_type": "press_release",
          "locator": "A Record Year for Biosimilar Approvals",
          "quote": "This milestone is due to CDER approving in 2024 a record total of 18 biosimilars for 8 reference products, more than any previous year.",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "U.S. Food and Drug Administration. (2024). CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024. Retrieved September 17, 2026, from https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Via StatOrigin, https://statorigin.org/stat/stat_60N9V7K4M162PZDBQ1S0114PD7",
          "bibtex": "@misc{fda2024reference114pd7,\n  author       = {{U.S. Food and Drug Administration}},\n  title        = {CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024},\n  year         = {2024},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_60N9V7K4M162PZDBQ1S0114PD7},\n  note         = {Original source: https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_KFKKPT8WMV7SZNK97MNH91JVAB",
        "url": "https://statorigin.org/stat/stat_KFKKPT8WMV7SZNK97MNH91JVAB",
        "indicator": {
          "slug": "share-of-first-cycle-novel-drug-approvals",
          "name": "Share of first-cycle novel drug approvals",
          "definition": "Percentage of novel drug approvals granted on the first regulatory review cycle."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "US",
          "name": "United States",
          "type": "country"
        },
        "period": {
          "start": "2024-01-01",
          "end": "2024-12-31",
          "type": "year"
        },
        "value": 74,
        "value_text": "74%",
        "unit": "percent",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "U.S. Food and Drug Administration",
          "org_short_name": "FDA",
          "org_url": "https://www.fda.gov",
          "org_tier": 1,
          "document_title": "CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024",
          "document_url": "https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024",
          "document_type": "press_release",
          "locator": "CDER’s Effectiveness Bringing New Therapies to Market",
          "quote": "First Cycle Approvals: 37 of the 50 novel drugs approved in 2024 (74%) were approved on the “first cycle” of review.",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "U.S. Food and Drug Administration. (2024). CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024. Retrieved September 17, 2026, from https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Via StatOrigin, https://statorigin.org/stat/stat_KFKKPT8WMV7SZNK97MNH91JVAB",
          "bibtex": "@misc{fda2024share91jvab,\n  author       = {{U.S. Food and Drug Administration}},\n  title        = {CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024},\n  year         = {2024},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_KFKKPT8WMV7SZNK97MNH91JVAB},\n  note         = {Original source: https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_6W7HZQ6HFKV7TZH7ZBNN5EA5VG",
        "url": "https://statorigin.org/stat/stat_6W7HZQ6HFKV7TZH7ZBNN5EA5VG",
        "indicator": {
          "slug": "share-of-novel-drug-approvals-meeting-user-fee-goal-dates",
          "name": "Share of novel drug approvals meeting user fee goal dates",
          "definition": "Percentage of novel drug approvals concluded within standard statutory or user fee review timelines."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "US",
          "name": "United States",
          "type": "country"
        },
        "period": {
          "start": "2024-01-01",
          "end": "2024-12-31",
          "type": "year"
        },
        "value": 94,
        "value_text": "94%",
        "unit": "percent",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "U.S. Food and Drug Administration",
          "org_short_name": "FDA",
          "org_url": "https://www.fda.gov",
          "org_tier": 1,
          "document_title": "CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024",
          "document_url": "https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024",
          "document_type": "press_release",
          "locator": "CDER’s Effectiveness Bringing New Therapies to Market",
          "quote": "User Fee Goal Performance: In 2024, CDER met or exceeded its Prescription Drug User Fee Act goal date for 47 of the 50 novel drug approvals (94%).",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "U.S. Food and Drug Administration. (2024). CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024. Retrieved September 17, 2026, from https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Via StatOrigin, https://statorigin.org/stat/stat_6W7HZQ6HFKV7TZH7ZBNN5EA5VG",
          "bibtex": "@misc{fda2024share5ea5vg,\n  author       = {{U.S. Food and Drug Administration}},\n  title        = {CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024},\n  year         = {2024},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_6W7HZQ6HFKV7TZH7ZBNN5EA5VG},\n  note         = {Original source: https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_GPDXVFNV1NK89Y6RJ0CJ62CWF4",
        "url": "https://statorigin.org/stat/stat_GPDXVFNV1NK89Y6RJ0CJ62CWF4",
        "indicator": {
          "slug": "share-of-novel-drug-approvals-using-expedited-programs",
          "name": "Share of novel drug approvals using expedited programs",
          "definition": "Percentage of novel therapies approved through one or more expedited regulatory review pathways."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "US",
          "name": "United States",
          "type": "country"
        },
        "period": {
          "start": "2024-01-01",
          "end": "2024-12-31",
          "type": "year"
        },
        "value": 66,
        "value_text": "66%",
        "unit": "percent",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "U.S. Food and Drug Administration",
          "org_short_name": "FDA",
          "org_url": "https://www.fda.gov",
          "org_tier": 1,
          "document_title": "CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024",
          "document_url": "https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024",
          "document_type": "press_release",
          "locator": "CDER’s Effectiveness Bringing New Therapies to Market",
          "quote": "Expedited Programs: In 2024, CDER approved 33 of the 50 new therapies (66%) using one or more expedited approval programs: fast track designation, breakthrough therapy designation, priority review designation, and Accelerated Approval.",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "U.S. Food and Drug Administration. (2024). CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024. Retrieved September 17, 2026, from https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Via StatOrigin, https://statorigin.org/stat/stat_GPDXVFNV1NK89Y6RJ0CJ62CWF4",
          "bibtex": "@misc{fda2024share62cwf4,\n  author       = {{U.S. Food and Drug Administration}},\n  title        = {CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024},\n  year         = {2024},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_GPDXVFNV1NK89Y6RJ0CJ62CWF4},\n  note         = {Original source: https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_3FQDDZSNS2RKBDYADECHD754YY",
        "url": "https://statorigin.org/stat/stat_3FQDDZSNS2RKBDYADECHD754YY",
        "indicator": {
          "slug": "share-of-novel-drugs-approved-first-in-domestic-market",
          "name": "Share of novel drugs approved first in domestic market",
          "definition": "Percentage of novel drugs approved in the reporting jurisdiction prior to receiving approval in other jurisdictions."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "US",
          "name": "United States",
          "type": "country"
        },
        "period": {
          "start": "2024-01-01",
          "end": "2024-12-31",
          "type": "year"
        },
        "value": 68,
        "value_text": "68%",
        "unit": "percent",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "U.S. Food and Drug Administration",
          "org_short_name": "FDA",
          "org_url": "https://www.fda.gov",
          "org_tier": 1,
          "document_title": "CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024",
          "document_url": "https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024",
          "document_type": "press_release",
          "locator": "CDER’s Effectiveness Bringing New Therapies to Market",
          "quote": "Approval in the U.S. Before Other Countries: In 2024, 34 of the 50 novel drugs approved by CDER (68%) were approved in the U.S. before being approved in other countries.",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "U.S. Food and Drug Administration. (2024). CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024. Retrieved September 17, 2026, from https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Via StatOrigin, https://statorigin.org/stat/stat_3FQDDZSNS2RKBDYADECHD754YY",
          "bibtex": "@misc{fda2024shared754yy,\n  author       = {{U.S. Food and Drug Administration}},\n  title        = {CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024},\n  year         = {2024},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_3FQDDZSNS2RKBDYADECHD754YY},\n  note         = {Original source: https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      }
    ]
  },
  "meta": {
    "attribution": "Data from StatOrigin (https://statorigin.org), CC BY 4.0. Attribution required.",
    "license": "https://creativecommons.org/licenses/by/4.0/",
    "docs": "https://statorigin.org/docs/api",
    "total": 18,
    "note": "Statistics are capped at 100 per request. Use /statistics?source_org=us-food-and-drug-administration with a cursor to page through everything."
  }
}